Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GOT1 | P17174 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29943503 | 1.00 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1IDO1KDM4ENPC1 | |
| SCHEMBL6017122 | 0.78 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1IDO1KDM4ENPC1 | |
| SCHEMBL3322710 | 0.76 | HDAC4 (0.38) | ALDH1A1L3MBTL1KDM4EHSD17B10HDAC4 | |
| SCHEMBL3704382 | 0.75 | HTR2C (0.38) | GAAHDAC4HTR2CMEN1KMT2A | |
| SCHEMBL34461976 | 0.75 | GABRG2 (0.47) | ALDH1A1L3MBTL1IDO1KDM4ENPC1 | |
| SCHEMBL8138036 | 0.75 | IDO1 (0.44) | ALDH1A1IDO1HSD17B10SMN1; SMN2RAB9A | |
| SCHEMBL30717913 | 0.75 | IDO1 (0.44) | ALDH1A1IDO1HSD17B10SMN1; SMN2RAB9A | |
| SCHEMBL8893831 | 0.75 | LMNA (0.48) | ALDH1A1IDO1KDM4ENPC1GAA | |
| SCHEMBL3464878 | 0.75 | NPC1 (0.45) | ALDH1A1L3MBTL1IDO1KDM4ENPC1 | |
| SCHEMBL29942556 | 0.75 | IDO1 (0.44) | ALDH1A1IDO1HSD17B10SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115943190-A | Multifunctional material for temporary bonding | 布鲁尔科技公司 | 2023-04-07 | — | — | CN | claimed |
| WO-2024058617-A1 | ANTIVIRAL USE OF HETEROARYL DERIVATIVE COMPOUND | 일동제약(주) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024019541-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 일동제약(주) | 2024-01-25 | — | — | WO | disclosed |
| CN-110462401-B | Use of enhancers of cellular autophagy for sensitizing tumors to radiotherapy | 古斯塔夫·鲁西研究所 | 2023-01-17 | — | — | CN | disclosed |
| US-11517575-B2 | Use of minaprine to reduce tumor growth | INSTITUT GUSTAVE ROUSSY (FR) | 2022-12-06 | — | — | US | disclosed |
| US-11471463-B2 | Enhancers of cellular cannibalism for use to sensitize tumors to radiation therapy | INSTITUT GUSTAVE ROUSSY (FR) | 2022-10-18 | — | — | US | disclosed |
| CN-110249004-B | Polyimide precursor composition | 东京应化工业株式会社 | 2022-07-19 | — | — | CN | disclosed |
| CN-108389512-B | Laminate, flexible device, and method for producing laminate | 东京应化工业株式会社 | 2022-04-15 | — | — | CN | disclosed |
| CN-108387954-B | Laminate, flexible device, and method for producing laminate | 东京应化工业株式会社 | 2022-01-18 | — | — | CN | disclosed |
| EP-3743721-B1 | MINAPRINE FOR USE IN REDUCING TUMOR GROWTH | ROUSSY INST GUSTAVE (FR) | 2021-11-17 | — | — | EP | disclosed |
| EP-1693434-A2 | Soot dispersants and lubricating oil compositions containing same | Infineum International Limited (GB) | 2006-08-23 | — | — | EP | disclosed |
| US-20060116299-A1 | Lubricating oil compositions | INFINEUM INTERNATIONAL LIMITED (GB) | 2006-06-01 | — | — | US | disclosed |
| US-20060116300-A1 | Lubricating oil compositions | INFINEUM INTERNATIONAL LIMITED (GB) | 2006-06-01 | — | — | US | disclosed |
| EP-1661970-A1 | Lubricating Oil Compositions | Infineum International Limited (GB) | 2006-05-31 | — | — | EP | disclosed |
| EP-1661969-A1 | Lubricating oil compositions | Infineum International Limited (GB) | 2006-05-31 | — | — | EP | disclosed |
| EP-1621602-A1 | Lubricating oil compositions | Infineum International Limited (GB) | 2006-02-01 | — | — | EP | disclosed |
| US-20050119138-A1 | Lubricating oil compositions | RITCHIE ANDREW J (US) | 2005-06-02 | — | — | US | disclosed |
| EP-1398365-A2 | Lubricating oil compositions for EGR equipped diesel engines | Infineum International Limited (GB) | 2004-03-17 | — | — | EP | disclosed |
| EP-0223974-A1 | N-Substituted-N-[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)-phenyl]alkanamides, carbamates and ureas | AMERICAN CYANAMID COMPANY (US) | 1987-06-03 | — | — | EP | disclosed |
| US-3947437-A | Substituted pyridazinyloxy(thio)phenyl ureas and derivatives thereof | THE DOW CHEMICAL COMPANY (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11517575-B2 | Use of minaprine to reduce tumor growth | METAP1, METAP2, CMA1 | ALDH1A1 1147/4885L3MBTL1 1857/4885IDO1 201/4885 |
| US-11471463-B2 | Enhancers of cellular cannibalism for use to sensitize tumors to radiation therapy | CMA1, LY96, CD74 | ALDH1A1 2899/4885L3MBTL1 3071/4885IDO1 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.